Liquidia (NASDAQ:LQDA) CEO Sells $764,863.40 in Stock

Liquidia Corporation (NASDAQ:LQDA) CEO Roger Jeffs sold 18,839 shares of Liquidia stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $40.60, for a total value of $764,863.40. Following the completion of the transaction, the chief executive officer owned 1,423,095 shares in the company, valued at $57,777,657. The trade was a 1.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $40.14, for a total value of $1,003,500.00.
• On Tuesday, April 14th, Roger Jeffs sold 3,300 shares of Liquidia stock. The shares were sold at an average price of $40.00, for a total value of $132,000.00.
• On Monday, April 13th, Roger Jeffs sold 32,744 shares of Liquidia stock. The shares were sold at an average price of $38.37, for a total value of $1,256,387.28.
• On Friday, April 10th, Roger Jeffs sold 21,433 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total value of $859,891.96.
• On Thursday, April 9th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.12, for a total value of $1,003,000.00.

Liquidia Price Performance

Shares of LQDA stock traded down $1.41 during trading hours on Tuesday, hitting $36.25. The company had a trading volume of 1,160,371 shares, compared to its average volume of 1,754,068. Liquidia Corporation has a 12 month low of $11.85 and a 12 month high of $46.67. The firm has a market capitalization of $3.19 billion, a price-to-earnings ratio of -43.67 and a beta of 0.45. The firm’s fifty day moving average is $36.46 and its 200 day moving average is $33.52. The company has a debt-to-equity ratio of 2.97, a quick ratio of 1.84 and a current ratio of 2.01.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Thursday, March 5th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.08 by $0.07. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The business had revenue of $92.02 million for the quarter, compared to the consensus estimate of $87.49 million. Liquidia’s revenue was up 3072.4% compared to the same quarter last year. On average, sell-side analysts predict that Liquidia Corporation will post 1.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on LQDA shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Liquidia in a report on Thursday, January 22nd. Wells Fargo & Company increased their target price on Liquidia from $44.00 to $51.00 and gave the stock an “overweight” rating in a report on Monday, March 23rd. Needham & Company LLC increased their target price on Liquidia from $52.00 to $54.00 and gave the stock a “buy” rating in a report on Thursday, March 5th. Lifesci Capital upgraded Liquidia to a “strong-buy” rating in a report on Thursday, March 5th. Finally, Raymond James Financial reiterated a “strong-buy” rating on shares of Liquidia in a report on Thursday, March 5th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Liquidia currently has an average rating of “Moderate Buy” and a consensus target price of $43.44.

Institutional Investors Weigh In On Liquidia

Several hedge funds have recently bought and sold shares of the company. Farallon Capital Management LLC lifted its position in Liquidia by 1.1% during the fourth quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company’s stock worth $298,547,000 after acquiring an additional 90,400 shares during the last quarter. Vanguard Group Inc. lifted its position in Liquidia by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock worth $138,439,000 after acquiring an additional 52,671 shares during the last quarter. Opaleye Management Inc. lifted its position in Liquidia by 9.5% during the second quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock worth $30,838,000 after acquiring an additional 215,000 shares during the last quarter. Caprock Group LLC lifted its position in Liquidia by 9.3% during the fourth quarter. Caprock Group LLC now owns 1,783,921 shares of the company’s stock worth $61,527,000 after acquiring an additional 151,832 shares during the last quarter. Finally, TCG Crossover Management LLC acquired a new stake in Liquidia during the third quarter worth approximately $38,887,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).